Could activated T cells play a major role in driving neurodegeneration in glaucoma?

A promising candidate is on the verge of entering clinical development… What happens when you see an opportunity to make it even better?

For better diagnosis and monitoring of Alzheimer’s disease, as well as drug R&D, we need to move toward widespread use of MRI biomarker imaging.

Women, like men, want good medicines that have been tested in clinical trials involving fair representation of both sexes.

A simple yet accurate model could help streamline ROP screening

MALDI and a SpiderMass device could save valuable surgery time

Regulators step in to stop stem cell clinics from marketing unproven therapies.

Introducing the easy-to-use system that offers patients lower risks of complications – regardless of surgeon experience

Talking at women in cannabis science, and meeting Raphael Mechoulam

Researchers identified the cell types associated with schizophrenia mutations